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Figure S1. UV-Vis absorption spectra (500-700 nm due to the light scattering) of self-assembled condensation products of 1 at 1mM with (Red) or without (black) the addition of 2 equiv. of TCEP at pH 7.4. HNMR spectra were obtained on a 300MHz Bruker AV 300. MALDI-TOF/TOF mass spectra were obtained on a time-of-flight Ultrflex Ⅱ mass spectrometer (Bruker Daltonics), HPLC analyses were performed on an Agilent 1200 HPLC system equipped with a G1322A pump and in-line diode array UV detector using a YMC-Pack ODS-AM column with CH 3 OH (0.1% of TFA) and water (0.1% of TFA) as the eluent. Dynamic light scattering (DLS) was measured on a Zeta Sizer Nano Series (Malvern Instruments). Scan electron micrograph (SEM) images were obtained on JEOL-JSM-6700F electron microscope at an accelerating voltage of 5.0KV. Transmission electron micrograph (TEM) images were obtained on a JEOL 2010 electron microscope, operating at 100 kV. The cryo-dried samples were prepared as following: a copper grid coated with carbon was dipped into the suspension solvent and placed into a vial, which was plunged into liquid nitrogen until no bubbles were apparent. Then water was removed from the frozen specimen by a freeze-drier. Fluorescence images were taken on an IVIS Lumina (Caliper LifeSciences) equipped with a cooled charge-coupled device (CCD) camera.
Chemical synthesis and characterization of monomers 1, 1-Ac, 2, and 2-Scr
The preparations of compound 1, 1-Ac, 2, 2-Scr were described as below; 2-cyano-6-aminobenzothiazole (CBT) was synthesized following the literature method (White, E. 
Synthesis of A:
The isobutyl chloroformate (109 mg, 0.8 mmol) was added to a mixture of Boc-Lys(Fmoc)-OH (375 mg, 0.8 mmol) and MMP (4-methylmorpholine, 151mg, 1.5 mmol) in THF (5.0 mL) at 0 °C under N 2 and the reaction mixture was stirred for 20 min. The solution of 2-cyano-6-aminobenzothiazole (140 mg, 0.8 mmol) was added to the reaction mixture and further stirred for 1 h at 0 °C then overnight at room temperature. Water (50 mL) was added and the reaction mixture was extracted with ethyl acetate (2 X 100 mL). The combined organic phase was dried by Na 2 SO 4 and then evaporated. The pure product A (195 mg, yield: 39%) was obtained after normal flash chromatography (eluent: AcOEt : Hexane = 1 : 1).
Synthesis of compound B:
The Boc protecting group of A was cleaved with 90% TFA in CH 2 Cl 2 for 3 h. Precipitated from the cleavage solution using cold diethyl ether, the amino CBT compound B was obtained in good yield which was directly used for next step reaction. The mixture of B (300 mg, 0.6 mmol), Boc-Cys(SEt)-OH•DCHA (334 mg, 0.72 mmol) and HBTU (300 mg, 0.72 mmol) in DMF (3 mL) was stirred overnight in presence of DIPEA (100 mg, 0.9 mmol). After normal workup, the compound C was obtained (355 mg, yield: 75% 
Synthesis of Acetyl-Asp-Glu-Val-Asp-Cys(StBu)-Lys(Biotin)-CBT (2):
Peptide C(StBu)DVED (88 mg, 0.10 mmol) was prepared by solid phase peptide synthesis (SPPS) and then coupled to G with the same method as above, followed by labeling with biotin NHS ester in DMF for 2hrs, then purified by HPLC to yield 2 (9.6 mg, yield: 7.8%). 1 HNMR of compound 2 (d 6 -DMSO, 300 MHz, 1 HNMR spectrum of compound 2-Scr.
